Early gliflozin for older patients with worsening heart failure
Part of Heart & circulation clinical trials.
This trial tests a medicine (a gliflozin) given in the emergency department to older patients with worsening heart failure. It aims to see if early treatment can help them feel better and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 75 or older
- Currently in the emergency department with heart failure symptoms
- Not taking gliflozin (a type of diabetes medicine) at the time
- Expected to be admitted to the hospital
- No severe kidney problems (eGFR less than 25)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called dapagliflozin can improve heart function in people hospitalized with acute heart failure. It may help the heart pump more efficiently and improve recovery.
This Phase 3 trial tests whether starting an SGLT2 inhibitor early in the hospital can improve outcomes for people at high risk after acute (sudden) heart failure. If you qualify, you would be randomized to receive the study medicine or standard care, started within 12 hours of admission.
This trial tests if dapagliflozin or acetazolamide works better for people hospitalized with heart failure who have extra fluid in their body (congestion). The study will compare how well each medication helps remove fluid when used with standard IV diuretics.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
This study tests whether a medicine called an SGLT2 inhibitor (which lowers blood sugar and helps the kidneys) can improve outcomes for people with acute heart failure and kidney problems. Participation involves taking the study drug or a placebo for a short time.
This study tests whether a medication called empagliflozin (a diabetes drug) can improve heart function in older adults with high blood pressure and obesity who are at risk for heart failure but do not have it yet. You would take the pill daily and have heart ultrasounds to check your heart's health.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.